{"id":"https://openalex.org/W2897874044","doi":"https://doi.org/10.26442/terarkh201890723-29","title":"Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases","display_name":"Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases","publication_year":2018,"publication_date":"2018-07-15","ids":{"openalex":"https://openalex.org/W2897874044","doi":"https://doi.org/10.26442/terarkh201890723-29","mag":"2897874044","pmid":"https://pubmed.ncbi.nlm.nih.gov/30701919"},"language":"en","primary_location":{"id":"doi:10.26442/terarkh201890723-29","doi":"https://doi.org/10.26442/terarkh201890723-29","is_oa":true,"landing_page_url":"https://doi.org/10.26442/terarkh201890723-29","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/32759/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},"volume":null,"type":"editorial","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://ter-arkhiv.ru/0040-3660/article/download/32759/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069763928","display_name":"Anait Levonovna Melikyan","orcid":"https://orcid.org/0000-0002-2119-3775","observed_orcids":["https://orcid.org/0000-0002-2119-3775"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A L MELIKYAN","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018301734","display_name":"Irina Nikolaevna Subortseva","orcid":"https://orcid.org/0000-0001-9045-8653","observed_orcids":["https://orcid.org/0000-0001-9045-8653"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"I N SUBORTSEVA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041606049","display_name":"Elena Gilyazitdinova","orcid":"https://orcid.org/0000-0002-3883-185X","observed_orcids":["https://orcid.org/0000-0002-3883-185X"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E A GILYAZITDINOVA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030894453","display_name":"Tamara I. Koloshejnova","orcid":"https://orcid.org/0000-0003-4580-040X","observed_orcids":["https://orcid.org/0000-0003-4580-040X"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"T I KOLOSHEJNOVA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038816801","display_name":"E. I. Pustovaya","orcid":"https://orcid.org/0000-0002-1099-8092","observed_orcids":["https://orcid.org/0000-0002-1099-8092"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E I PUSTOVAYA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068078725","display_name":"Egorova Ek","orcid":"https://orcid.org/0000-0001-6038-9474","observed_orcids":["https://orcid.org/0000-0001-6038-9474"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E K EGOROVA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043454332","display_name":"Alla Mikhailovna Kovrigina","orcid":"https://orcid.org/0000-0002-1082-8659","observed_orcids":["https://orcid.org/0000-0002-1082-8659"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A M KOVRIGINA","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046495435","display_name":"Andrey Borisovich Sudarikov","orcid":"https://orcid.org/0000-0001-9463-9187","observed_orcids":["https://orcid.org/0000-0001-9463-9187"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A B SUDARIKOV","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049170583","display_name":"\u0410 \u041e \u0410\u0431\u0434\u0443\u043b\u043b\u0430\u0435\u0432","orcid":"https://orcid.org/0000-0003-2530-808X","observed_orcids":["https://orcid.org/0000-0003-2530-808X"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A O ABDULLAEV","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080565087","display_name":"\u041b\u043e\u043c\u0430\u0438\u0430 \u0415\u043b\u0437\u0430 \u0413\u0430\u043b\u0430\u043a\u0442\u0438\u043e\u043d\u043e\u0432\u043d\u0430","orcid":"https://orcid.org/0000-0003-3290-7961","observed_orcids":["https://orcid.org/0000-0003-3290-7961"]},"institutions":[{"id":"https://openalex.org/I3018698992","display_name":"Federal Almazov North-West Medical Research Centre","ror":"https://ror.org/03qepc107","country_code":"RU","type":"facility","lineage":["https://openalex.org/I3018698992"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"E G LOMAIA","raw_affiliation_strings":["Almazov National Medical Research Center, Saint Petersburg, Russia","Almazov National Medical Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almazov National Medical Research Center, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I3018698992"]},{"raw_affiliation_string":"Almazov National Medical Research Center","institution_ids":["https://openalex.org/I3018698992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112444457","display_name":"Nadiya Tamazovna Siordiya","orcid":"https://orcid.org/0000-0001-7081-4999","observed_orcids":["https://orcid.org/0000-0001-7081-4999"]},"institutions":[{"id":"https://openalex.org/I3018698992","display_name":"Federal Almazov North-West Medical Research Centre","ror":"https://ror.org/03qepc107","country_code":"RU","type":"facility","lineage":["https://openalex.org/I3018698992"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N T SIORDIYA","raw_affiliation_strings":["Almazov National Medical Research Center, Saint Petersburg, Russia","Almazov National Medical Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almazov National Medical Research Center, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I3018698992"]},{"raw_affiliation_string":"Almazov National Medical Research Center","institution_ids":["https://openalex.org/I3018698992"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059723473","display_name":"Andrey Yu. Zaritskey","orcid":"https://orcid.org/0000-0001-7682-440X","observed_orcids":["https://orcid.org/0000-0001-7682-440X"]},"institutions":[{"id":"https://openalex.org/I3018698992","display_name":"Federal Almazov North-West Medical Research Centre","ror":"https://ror.org/03qepc107","country_code":"RU","type":"facility","lineage":["https://openalex.org/I3018698992"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A Yu ZARITSKEY","raw_affiliation_strings":["Almazov National Medical Research Center, Saint Petersburg, Russia","Almazov National Medical Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Almazov National Medical Research Center, Saint Petersburg, Russia","institution_ids":["https://openalex.org/I3018698992"]},{"raw_affiliation_string":"Almazov National Medical Research Center","institution_ids":["https://openalex.org/I3018698992"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5014421357","display_name":"Savchenko Vg","orcid":"https://orcid.org/0000-0001-8188-5557","observed_orcids":["https://orcid.org/0000-0001-8188-5557"]},"institutions":[{"id":"https://openalex.org/I4210100648","display_name":"National Medical Research Center for Hematology","ror":"https://ror.org/015fskz95","country_code":"RU","type":"facility","lineage":["https://openalex.org/I4210100648","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"V G SAVCHENKO","raw_affiliation_strings":["National Research Center for hematology, Moscow, Russia","National Research Center for hematology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Research Center for hematology, Moscow, Russia","institution_ids":["https://openalex.org/I4210100648"]},{"raw_affiliation_string":"National Research Center for hematology","institution_ids":["https://openalex.org/I4210100648"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"90","issue":"7","first_page":"23","last_page":"29"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10746","display_name":"Platelet Disorders and Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/peginterferon-alfa-2b","display_name":"peginterferon alfa-2b","score":0.9120000004768372},{"id":"https://openalex.org/keywords/myeloproliferative-neoplasms","display_name":"myeloproliferative neoplasms","score":0.9409999847412109},{"id":"https://openalex.org/keywords/polycythemia-vera","display_name":"polycythemia vera","score":0.9990000128746033},{"id":"https://openalex.org/keywords/essential-thrombocythemia","display_name":"essential thrombocythemia","score":1.0},{"id":"https://openalex.org/keywords/hydroxyurea","display_name":"hydroxyurea","score":0.9819999933242798},{"id":"https://openalex.org/keywords/recombinant-interferon-alpha","display_name":"recombinant interferon alpha","score":0.9620000123977661},{"id":"https://openalex.org/keywords/hematological-response","display_name":"hematologic response","score":0.7020000219345093},{"id":"https://openalex.org/keywords/phlebotomy","display_name":"phlebotomy","score":0.8119999766349792},{"id":"https://openalex.org/keywords/hematological-adverse-events","display_name":"hematologic adverse events","score":0.7860000133514404},{"id":"https://openalex.org/keywords/treatment-efficacy-comparison","display_name":"treatment efficacy comparison","score":0.6549999713897705}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9601467847824097},{"id":"https://openalex.org/C2779316324","wikidata":"https://www.wikidata.org/wiki/Q212272","display_name":"Hydroxycarbamide","level":3,"score":0.8244377374649048},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.721168041229248},{"id":"https://openalex.org/C2777357209","wikidata":"https://www.wikidata.org/wiki/Q3595842","display_name":"Phlebotomy","level":2,"score":0.6467321515083313},{"id":"https://openalex.org/C2781057849","wikidata":"https://www.wikidata.org/wiki/Q1368780","display_name":"Essential thrombocythemia","level":3,"score":0.5614869594573975},{"id":"https://openalex.org/C2778837598","wikidata":"https://www.wikidata.org/wiki/Q948318","display_name":"Polycythemia vera","level":2,"score":0.5383748412132263},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5277788639068604},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5143145322799683},{"id":"https://openalex.org/C2780829020","wikidata":"https://www.wikidata.org/wiki/Q408163","display_name":"Anagrelide","level":4,"score":0.453927218914032},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3978726267814636},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.39161065220832825},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3362886905670166}],"mesh":[{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000077190","descriptor_name":"Interferon alpha-2","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005787","descriptor_name":"Gene Frequency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006918","descriptor_name":"Hydroxyurea","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011087","descriptor_name":"Polycythemia Vera","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D011087","descriptor_name":"Polycythemia Vera","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D011087","descriptor_name":"Polycythemia Vera","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011092","descriptor_name":"Polyethylene Glycols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013920","descriptor_name":"Thrombocythemia, Essential","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013920","descriptor_name":"Thrombocythemia, Essential","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D013920","descriptor_name":"Thrombocythemia, Essential","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016898","descriptor_name":"Interferon-alpha","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D053614","descriptor_name":"Janus Kinase 2","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.26442/terarkh201890723-29","doi":"https://doi.org/10.26442/terarkh201890723-29","is_oa":true,"landing_page_url":"https://doi.org/10.26442/terarkh201890723-29","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/32759/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},{"id":"pmid:30701919","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30701919","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"Clinical Trial"},{"id":"pmh:oai:doaj.org/article:24b0a0e7af394e34811b114da05d6bfc","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/24b0a0e7af394e34811b114da05d6bfc","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0422\u0435\u0440\u0430\u043f\u0435\u0432\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0430\u0440\u0445\u0438\u0432, Vol 90, Iss 7, Pp 23-29 (2018)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.26442/terarkh201890723-29","doi":"https://doi.org/10.26442/terarkh201890723-29","is_oa":true,"landing_page_url":"https://doi.org/10.26442/terarkh201890723-29","pdf_url":"https://ter-arkhiv.ru/0040-3660/article/download/32759/pdf","source":{"id":"https://openalex.org/S27897580","display_name":"Terapevticheskii arkhiv","issn_l":"0040-3660","issn":["0040-3660","2309-5342"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","jufo-1","medline","norway-1","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4320800547","host_organization_name":"Consilium Medicum","host_organization_lineage":["https://openalex.org/P4320800547"],"host_organization_lineage_names":["Consilium Medicum"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Terapevticheskii arkhiv","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2897874044.pdf","grobid_xml":"https://content.openalex.org/works/W2897874044.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W2010298229","https://openalex.org/W2011059916","https://openalex.org/W2024706907","https://openalex.org/W2083179131","https://openalex.org/W2094456737","https://openalex.org/W2094487700","https://openalex.org/W2097692898","https://openalex.org/W2185322154","https://openalex.org/W2767250221"],"related_works":["https://openalex.org/W2972422263","https://openalex.org/W4405049612","https://openalex.org/W2983517120","https://openalex.org/W2097692898","https://openalex.org/W4205527069","https://openalex.org/W4200370164","https://openalex.org/W2767250221","https://openalex.org/W2490277447","https://openalex.org/W4310093707","https://openalex.org/W4213412710"],"abstract_inverted_index":{"AIM:":[0],"A":[1],"comparative":[2],"evaluation":[3],"of":[4,7,47,59,77,89,134,156,159,176,192,199,219,273,335,344,361,425,430,443,480,503,507],"the":[5,32,39,71,73,82,94,102,137,142,148,153,160,163,177,189,202,216,237,280,296,307,326,333,341,352,358,366,413,423,426,455,481,501,508],"effectiveness":[6],"different":[8,203],"therapeutic":[9,204,490],"strategies":[10],"in":[11,38,70,120,132,136,141,147,181,197,250,262,306,316,398,404,416,432,437,445,469,472],"patients":[12,67,79,99,107,124,135,161,263,318,446,457],"with":[13,25,84,110,242,300,332,351,380,408,447,474],"polycythemia":[14],"vera":[15],"(PV)":[16],"and":[17,50,145,174,286,309,315,388,449,460,476],"essential":[18],"thrombocythemia":[19],"(ET).":[20],"MATERIALS":[21],"AND":[22],"METHODS:":[23],"Patients":[24],"PV":[26,448],"or":[27],"ET,":[28],"diagnosed":[29],"according":[30,495],"to":[31,224,228,232,245,386,496],"criteria":[33],"WHO":[34],"2016":[35],"were":[36,68,108,122,128,258,304,377,396,464],"included":[37,69],"study.":[40],"The":[41,53,235,322,410,478,488],"primary":[42],"endpoint":[43,55],"-":[44,56,97,105,401,454],"6":[45],"months":[46,58],"therapy":[48,60,83,114,127,274,334,414],"(clinical-hematological":[49],"molecular":[51],"responses).":[52,64],"secondary":[54],"12":[57],"(clinico-hematologic,":[61],"molecular,":[62],"histological":[63],"Sixty":[65],"three":[66,214],"analysis:":[72],"first":[74,138,342],"group":[75,96,104,298,417,433,438],"consisted":[76],"33":[78],"who":[80],"received":[81,91],"ce-pegiterferone":[85],"alpha-2b":[86],"(ce-pegalpha-INF-\u03b1-2b),":[87],"10":[88],"them":[90],"previous":[92],"treatment;":[93],"second":[95,143,297],"23":[98],"btained":[100],"hydroxycarbamide;":[101],"third":[103,149],"7":[106],"treated":[109,407],"recombinant":[111],"interferon":[112],"alpha":[113],"(rINF\u03b1).":[115],"In":[116,212,295],"comparison":[117,473],"groups,":[118,215],"differences":[119,196,468],"age":[121],"revealed:":[123],"receiving":[125,162,264],"hydroxycarbamide":[126,301,475],"older.":[129],"Phlebotomy":[130],"occurred":[131],"36%":[133,169],"group,":[139,144],"9%":[140],"14%":[146],"group.":[150],"RESULTS:":[151],"By":[152,188],"6th":[154],"month":[155,191,343,360],"therapy,":[157,193,246],"43%":[158],"ce-pegalpha-INF-\u03b1-2b":[164,265,444,482],"had":[165,170,383,483],"complete":[166],"clinical-hematologic":[167,172],"response,":[168],"partial":[171],"remission":[173],"stabilization":[175],"disease":[178,185],"was":[179,248,325,347],"established":[180],"21%":[182],"cases.":[183],"No":[184],"progression":[186],"occured.":[187],"12th":[190],"statistically":[194,466],"significant":[195,467],"terms":[198],"efficacy":[200,429],"between":[201],"groups":[205],"(p":[206],"=":[207],"0.2462,":[208],"Fisher's":[209],"exact":[210],"test).":[211],"all":[213,251],"allelic":[217],"load":[218,239],"JAK2V617F":[220],"decreased:":[221],"from":[222,226,230],"50":[223,231],"19%,":[225],"22.3":[227],"15.8%,":[229],"7.19%,":[233],"respectively.":[234],"lower":[236],"allele":[238],"positively":[240],"correlated":[241],"better":[243],"response":[244],"which":[247,337],"observed":[249,261,356],"analyzed":[252],"groups.":[253],"Hematologic":[254],"adverse":[255,329],"events":[256],"(AEs)":[257],"more":[259],"frequently":[260],"therapy.":[266,345,362],"Local":[267],"reactions":[268,285],"developed":[269],"on":[270,292,374],"3-7":[271],"days":[272],"as":[275],"a":[276,364,384,405],"hyperemic":[277],"macula":[278],"at":[279,357],"injection":[281],"site.":[282],"Both":[283],"these":[284,470],"hair":[287],"loss":[288],"did":[289,371,389],"not":[290,372,390],"influence":[291,373],"patient's":[293,375],"condition.":[294],"(patients":[299],"therapy)":[302],"there":[303],"changes":[305,370],"skin":[308,435],"mucous":[310],"membranes:":[311],"dry":[312],"skin,":[313],"stomatitis,":[314],"older":[317],"new":[319],"keratomas":[320],"appeared.":[321],"flu-like":[323,353],"syndrome":[324,354],"most":[327,456],"common":[328],"event":[330],"associated":[331,379],"ce-pegalpha-INF-\u03b1-2b,":[336],"fully":[338],"relived":[339],"during":[340],"There":[346,463],"only":[348],"one":[349,399],"case":[350,400],"we":[355],"11th":[359],"As":[363],"rule,":[365],"biochemical":[367],"blood":[368],"test":[369],"condition,":[376],"mostly":[378],"dietary":[381],"violations,":[382],"tendency":[385],"self-resolution":[387],"require":[391],"medical":[392],"interventions.":[393],"Serious":[394],"AEs":[395],"reported":[397],"pulmonary":[402],"embolism":[403],"patient":[406],"rINF\u03b1.":[409,477],"reasons":[411],"for":[412],"discontinue":[415],"1:":[418],"toxic":[419],"hepatitis,":[420],"intolerance,":[421],"by":[422],"request":[424],"patient,":[427],"inadequate":[428],"therapy;":[431],"2:":[434],"toxicity,":[436],"3:":[439],"thromboses.":[440],"CONCLUSION:":[441],"Treatment":[442],"ET":[450],"is":[451,511],"highly":[452],"effective":[453],"pbtained":[458],"clinical":[459],"hematological":[461],"responses.":[462],"no":[465],"parameters":[471],"use":[479],"an":[484],"acceptable":[485],"safety":[486],"profile.":[487],"estimated":[489],"dose":[491,510],"should":[492],"be":[493],"calculated":[494],"body":[497],"weight.":[498],"To":[499],"reduce":[500],"frequency":[502],"hematologic":[504],"AE,":[505],"titration":[506],"drug":[509],"required.":[512]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2018-10-26T00:00:00"}